CK Life Sciences Int'l., (Holdings) Inc. (0775.HK) HKSE

Currency In HKD

AD

CK Life Sciences Int'l., (Holdings) Inc.

Address

2 Dai Fu Street

Tai Po,

Hong Kong

Phone

852 2126 1212

Sector

Healthcare

Industry

Biotechnology

Employees

2033

First IPO Date

July 16, 2002

Key Executives

NameTitlePayYear Born
Ying Choi YuCEO & Executive Deputy Chairman12.04M1956
Lee YuenVice President, Chief Executive Officer & Executive Director15.03M1966
Tzar Kuoi LiExecutive Chairman125,0001964
Tak ChuenSenior Vice President, Chief Investment Officer & Executive Director1.1M1952
Hing Lam KamPresident & Executive Director3.33M1946
Kean Meng TohVice President, Chief Scientific Officer & Executive Director6.78M1967
Yau Lin WongGeneral Manager of Human Resources & Administration01967
Pak To WuChief Operating Officer of Global Operations01962
Wai Che Tong BarnesChief Corporate Affairs Officer01960
Emily TanChief Operating Officer0N/A
Sze MunVice President of Corporate Development01972
Ching Sze ChiuGeneral Counsel01977
Wun Lam WongChief Financial Officer01965
AD

Description

CK Life Sciences International (Holdings) Inc., established in 1999 and headquartered in Tai Po, Hong Kong, functions as an investment holding company with significant operations in health and agriculture across the Asia Pacific and North American markets. Its agricultural division encompasses the research, development, production, commercialization, marketing, and distribution of a wide array of products. This includes plant protection solutions, soluble and various other fertilizers, pesticides, and general agricultural goods. The company also produces and distributes horticultural products for home use, licenses registration activities, and imports finished agricultural products. Further extending its reach, it supplies turf management machinery, hardware, equipment, accessories, specialized turf fertilizers, chemicals, and professional pest control items. Additionally, it is involved in the production, refining, and distribution of salt. In the health and life sciences sector, CK Life Sciences manufactures non-sterile prescription and over-the-counter medicines. It provides contract manufacturing for complementary healthcare products, pharmaceuticals, and cosmetics. The company conducts research, development, manufacturing, and commercialization of drug products, particularly for pain management and melanoma. It also trades in biotechnology products and nutritional supplements, alongside the manufacturing, wholesaling, retailing, and distribution of nutraceutical products. Furthermore, it supplies raw materials to the nutritional health, pharmaceutical, cosmetics, personal care, and food industries, while also offering research and development services for biotechnology and life sciences technologies. Beyond these core areas, its business activities include holding land and buildings, engaging in financing activities, making investments in financial instruments and vineyards, and providing packing and asset management services.

AD